Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates) - Global Forecasts to 2026

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 26
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY USED FOR THE STUDY
1.5             MAJOR MARKET STAKEHOLDERS
1.6             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 1.................................................. RESEARCH DESIGN.. 29
2.1.1              SECONDARY DATA
2.1.1.1            SECONDARY SOURCES
2.1.2              PRIMARY DATA
・       FIGURE 2.......... BREAKDOWN OF PRIMARIES: CONTINUOUS RENAL REPLACEMENT
THERAPY MARKET
2.2             MARKET ESTIMATION METHODOLOGY
・       FIGURE 3......... RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1              REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2              USAGE-BASED MARKET ESTIMATION
・       FIGURE 4............................. ESTIMATION OF CRRT PROCEDURES
・       FIGURE 5............. MARKET SIZE ESTIMATION: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BASED ON PRODUCT UTILIZATION METHODOLOGY
・       FIGURE 6............. MARKET SIZE ESTIMATION: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BASED ON REVENUE MAPPING METHODOLOGY
2.2.3              PRIMARY RESEARCH VALIDATION
2.3             DATA TRIANGULATION
・       FIGURE 7.......................... DATA TRIANGULATION METHODOLOGY
2.4             RESEARCH ASSUMPTIONS
2.5             RESEARCH LIMITATIONS

3.... EXECUTIVE SUMMARY

・       FIGURE 8 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)
・       FIGURE 9 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY,
2021 VS. 2026 (USD MILLION)
・       FIGURE 10.. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021 VS. 2026 (USD MILLION)
・       FIGURE 11. GEOGRAPHICAL SNAPSHOT OF THE CONTINUOUS RENAL
REPLACEMENT THERAPY MARKET

4.... PREMIUM INSIGHTS

4.1             CONTINUOUS RENAL REPLACEMENT THERAPY MARKET OVERVIEW
・       FIGURE 12 RISING PREVALENCE OF AKI AND GROWING AWARENESS ABOUT CRRT TO DRIVE MARKET GROWTH
4.2             CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY AGE GROUP, 2021
・       FIGURE 13 ADULTS SEGMENT TO DOMINATE THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET IN 2021
4.3             ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT AND COUNTRY
・       FIGURE 14.. DIALYSATES AND REPLACEMENT FLUIDS ACCOUNT FOR THE LARGEST SHARE OF THE CRRT PRODUCTS MARKET IN THE APAC
・       FIGURE 15. APAC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026)

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 16.. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              DRIVERS
5.2.1.1            INCREASING INCIDENCE OF ACUTE KIDNEY INJURY (AKI)
・       FIGURE 17..... GLOBAL INCIDENCE OF AKI, 2010 VS. 2015 VS. 2020
・       TABLE 1. NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 VS. 2050
5.2.1.2            GROWING NUMBER OF ICU PATIENTS WITH AKI AND INCREASING INCIDENCE OF SEPSIS
・       FIGURE 18...................... IMPACT OF ICU-ACQUIRED AKI IN THE US
5.2.1.3            INCREASING CLINICAL ADVANTAGE OF CRRT OVER INTERMITTENT BLOOD PURIFICATION
5.2.1.4            TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
5.2.1.5            GROWING PREVALENCE OF DIABETES AND HYPERTENSION
・       FIGURE 19... TOP 5 COUNTRIES WITH CHILDREN AND ADOLESCENTS WITH TYPE I DIABETES, 2019
5.2.2              RESTRAINTS
5.2.2.1            STRINGENT REGULATORY GUIDELINES IN NORTH AMERICA
5.2.2.2            HIGH PROCEDURAL COST OF CRRT
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGING MARKETS IN APAC AND ROW
5.2.3.2            INCREASING APPLICATIONS OF CRRT
5.2.3.2.1            EVOLUTION OF CRRT FROM A SIMPLE RENAL REPLACEMENT TREATMENT TO MULTI-ORGAN SUPPORT THERAPY
5.2.3.2.2            PROGRESSION OF CRRT FROM ADAPTIVE RENAL DEVICES TO MULTIPURPOSE TREATMENT MACHINES
5.2.3.3            ONGOING RESEARCH TO ESTABLISH THE SAFETY AND EFFICACY PROFILE OF CRRT
5.2.3.4            DEVELOPMENT OF CRRT SYSTEMS FOR PEDIATRIC PATIENTS
5.2.3.4.1            THE CARPEDIEM PROJECT
5.2.3.5            UNTAPPED GROWTH OPPORTUNITIES IN NORTH AMERICA
5.2.4              CHALLENGES
5.2.4.1            HIGH COMPLEXITY OF CRRT
5.2.4.2            LACK OF STANDARD TREATMENT GUIDELINES IN DEVELOPING NATIONS
5.2.4.3            SHORTAGE OF TRAINED ICU PROFESSIONALS IN DEVELOPING NATIONS
5.2.4.4            POOR REIMBURSEMENT SCENARIO IN DEVELOPING COUNTRIES
5.2.4.5            LACK OF AWARENESS ABOUT THE BENEFITS OF CRRT
5.3             GLOBAL REGULATORY LANDSCAPE
5.3.1              NORTH AMERICA
5.3.2              EUROPE
5.3.3              ASIA PACIFIC
5.3.3.1            INDIA
5.3.3.2            CHINA
5.3.3.3            JAPAN
5.3.3.4            SOUTH KOREA
5.3.4              REST OF THE WORLD (ROW)
5.3.4.1            BRAZIL
5.3.4.2            ARGENTINA
5.4             GLOBAL REIMBURSEMENT SCENARIO
5.4.1              NORTH AMERICA
5.4.2              EUROPE
5.4.3              ASIA PACIFIC
5.4.4              JAPAN
5.4.5              REST OF THE WORLD (ROW)
5.4.5.1            BRAZIL
5.4.5.2            CENTRAL AMERICA AND THE CARIBBEAN
5.5             COVID-19 IMPACT ON THE CRRT MARKET
・       FIGURE 20. US: COVID-19 HOSPITALIZATION DATA FOR SPECIALIZED MEDICAL CONDITIONS IN ADULTS (AS OF APRIL 11, 2020)
5.6             VALUE CHAIN ANALYSIS
・       FIGURE 21 VALUE CHAIN OF THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
5.7             ECOSYSTEM COVERAGE
5.8             PRICING TREND ANALYSIS
・       TABLE 2 AVERAGE PRICE OF CRRT SYSTEMS AND CONSUMABLES, BY COUNTRY, 2020 (USD)
5.9             PORTER’S FIVE FORCES ANALYSIS
・       TABLE 3...... CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1              THREAT FROM NEW ENTRANTS
・       FIGURE 22.................................. THREAT FROM NEW ENTRANTS
5.9.2              THREAT FROM SUBSTITUTES
・       FIGURE 23..................................... THREAT FROM SUBSTITUTES
5.9.3              BARGAINING POWER OF SUPPLIERS
・       FIGURE 24........................... BARGAINING POWER OF SUPPLIERS
5.9.4              BARGAINING POWER OF BUYERS
・       FIGURE 25............................... BARGAINING POWER OF BUYERS
5.9.5              INTENSITY OF COMPETITIVE RIVALRY
・       FIGURE 26........................... INTENSITY OF COMPETITIVE RIVALRY

6.... GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT

6.1             INTRODUCTION
・       TABLE 4.. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
6.2             DIALYSATES & REPLACEMENT FLUIDS
6.2.1              RISING DEMAND FOR DIALYSATES HAS SUPPORTED MARKET GROWTH
・       TABLE 5............. DIALYSATES & REPLACEMENT FLUIDS MARKET, BY MODALITY,
2019–2026 (USD MILLION)
・       TABLE 6....... DIALYSATES & REPLACEMENT FLUIDS MARKET, BY AGE GROUP,
2019–2026 (USD MILLION)
・       TABLE 7. DIALYSATES & REPLACEMENT FLUIDS MARKET, BY REGION,
2019–2026 (USD MILLION)
6.3             DISPOSABLES
・       TABLE 8........... DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 9.... DISPOSABLES MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 10 DISPOSABLES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
・       TABLE 11..... DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1              HEMOFILTERS
6.3.1.1            HEMOFILTERS ARE WIDELY ADOPTED DURING CRRT PROCEDURES FOR THE TREATMENT OF AKI
・       TABLE 12...... HEMOFILTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 13... HEMOFILTERS MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 14 HEMOFILTERS MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
6.3.2              BLOODLINE SETS & TUBES
6.3.2.1            ESTABLISHED PLAYERS ARE FOCUSING ON STRENGTHENING THEIR BLOODLINE SETS AND TUBES PRODUCT LINES
・       TABLE 15.... BLOODLINE SETS & TUBES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 16........... BLOODLINE SETS & TUBES MARKET, BY MODALITY,
2019–2026 (USD MILLION)
・       TABLE 17........ BLOODLINE SETS & TUBES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION)
6.3.3              OTHER DISPOSABLES.. 77
・       TABLE 18... OTHER DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 19 OTHER DISPOSABLES MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 20..... OTHER DISPOSABLES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
6.4             CRRT SYSTEMS
6.4.1              INTRODUCTION OF ADVANCED PRODUCTS TO DRIVE THE DEMAND
FOR CRRT SYSTEMS
・       TABLE 21. CRRT SYSTEMS MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 22 CRRT SYSTEMS MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
・       TABLE 23..... CRRT SYSTEMS MARKET BY REGION, 2019–2026 (USD MILLION)

7.... GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY

7.1             INTRODUCTION
・       TABLE 24. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION)
7.2             CONTINUOUS VENOVENOUS HEMOFILTRATION
7.2.1              WIDESPREAD ADOPTION OF CVVH IN THE TREATMENT OF ACUTE KIDNEY INJURY TO DRIVE MARKET GROWTH.. 82
・       TABLE 25 CONTINUOUS VENOVENOUS HEMOFILTRATION MARKET, BY REGION,
2019–2026 (USD MILLION)
7.3             CONTINUOUS VENOVENOUS HEMODIAFILTRATION
7.3.1              CVVHDF IS USED IN PATIENTS WITH CONGESTIVE HEART FAILURE
・       TABLE 26 CONTINUOUS VENOVENOUS HEMODIAFILTRATION MARKET, BY REGION, 2019–2026 (USD MILLION)
7.4             CONTINUOUS VENOVENOUS HEMODIALYSIS
7.4.1              THIS THERAPY IS MORE EFFECTIVE IN REMOVING SMALL TO MEDIUM-SIZED MOLECULES AS COMPARED TO OTHER CRRT MODALITIES
・       TABLE 27... CONTINUOUS VENOVENOUS HEMODIALYSIS MARKET, BY REGION,
2019–2026 (USD MILLION)
7.5             SLOW CONTINUOUS ULTRAFILTRATION
7.5.1              SCUF DOES NOT USE DIALYSATES OR REPLACEMENT FLUIDS FOR THE REMOVAL OF EXCESS FLUID FROM THE BLOODSTREAM
・       TABLE 28.......... SLOW CONTINUOUS ULTRAFILTRATION MARKET, BY REGION,
2019–2026 (USD MILLION)

8.... GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP

8.1             INTRODUCTION
・       TABLE 29. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
8.2             ADULTS
8.2.1              ADULTS HOLD THE LARGEST SHARE OF THE MARKET BY AGE GROUP
・       TABLE 30 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR ADULTS,
BY REGION, 2019–2026 (USD MILLION)
8.3             PEDIATRICS & NEONATES
8.3.1              HIGH PREVALENCE OF AKI IN NEONATES TO AID THE MARKET GROWTH DURING THE FORECAST PERIOD
・       TABLE 31 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR PEDIATRICS & NEONATES, BY REGION, 2019–2026 (USD MILLION)

9.... GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION

9.1             INTRODUCTION
・       TABLE 32. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION,
2019–2026 (USD MILLION)
9.2             EUROPE
・       FIGURE 27.. EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
・       TABLE 33.... EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 34.... EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 35.... EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 36.... EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 37.... EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION)
9.2.1              GERMANY
9.2.1.1            GERMANY IS THE LARGEST MARKET FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN EUROPE
・       TABLE 38.. GERMANY: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 39.. GERMANY: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.2.2              UK
9.2.2.1            RISING NUMBER OF SEPSIS CASES IN THE UK TO SUPPORT MARKET GROWTH
・       TABLE 40 UK: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 41........... UK: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.2.3              FRANCE
9.2.3.1            FRANCE IS THE FASTEST-GROWING MARKET FOR CRRT IN EUROPE
・       TABLE 42..... FRANCE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 43..... FRANCE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.2.4              ITALY
9.2.4.1            GOVERNMENT INITIATIVES TO PROMOTE THE AWARENESS OF CRRT FOR RENAL CARE TO DRIVE MARKET GROWTH
・       TABLE 44........ ITALY: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 45........ ITALY: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION
9.2.5              SPAIN
9.2.5.1            FAVORABLE REIMBURSEMENT SCENARIO TO FAVOR MARKET GROWTH
・       TABLE 46....... SPAIN: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 47....... SPAIN: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.2.6              REST OF EUROPE
・       TABLE 48.......... ROE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 49.......... ROE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3             NORTH AMERICA
・       TABLE 50...... NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 51...... NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 52...... NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 53...... NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 54...... NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION)
9.3.1              US
9.3.1.1            LARGE NUMBER OF AKI PATIENTS IN THE REGION TO DRIVE THE MARKET GROWTH.. 103
・       TABLE 55 US: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 56........... US: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.3.2              CANADA
9.3.2.1            HIGH COST OF CRRT AS COMPARED TO IHD IS NEGATIVELY IMPACTING MARKET GROWTH IN CANADA
・       TABLE 57.... CANADA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 58.... CANADA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4             ASIA PACIFIC
・       FIGURE 28...... APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
・       TABLE 59........ APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 60........ APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 61........ APAC: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 62........ APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 63........ APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)
9.4.1              JAPAN
9.4.1.1            INCREASING USE OF CRRT TO BOOST THE MARKET IN JAPAN
・       TABLE 64....... JAPAN: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 65....... JAPAN: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.2              CHINA
9.4.2.1            INCREASING PREVALENCE OF ESRD AND AKI TO BOOST THE
DEMAND FOR CRRT
・       TABLE 66....... CHINA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 67....... CHINA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.3              INDIA
9.4.3.1            GROWING NUMBER OF AKI PATIENTS AND ICU ADMISSIONS TO SUPPORT MARKET GROWTH
・       TABLE 68........ INDIA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 69........ INDIA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.4              AUSTRALIA
9.4.4.1            THE AUSTRALIAN GOVERNMENT IS TAKING VARIOUS INITIATIVES TO INCREASE THE AWARENESS OF CRRT
・       TABLE 70. AUSTRALIA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 71. AUSTRALIA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.5              SOUTH KOREA
9.4.5.1            THE COUNTRY IS WITNESSING AN INCREASING NUMBER OF PATIENTS RECEIVING CRRT FOR THE TREATMENT OF AKI
・       TABLE 72......... SOUTH KOREA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 73......... SOUTH KOREA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.4.6              REST OF ASIA PACIFIC
・       TABLE 74 REST OF ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 75 REST OF ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5             LATIN AMERICA
・       TABLE 76....... LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 77....... LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 78....... LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 79....... LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 80....... LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION)
9.5.1              BRAZIL
9.5.1.1            BRAZIL HOLDS THE LARGEST SHARE IN THE LATIN AMERICAN CRRT MARKET
・       TABLE 81...... BRAZIL: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 82...... BRAZIL: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5.2              MEXICO
9.5.2.1            LARGE PATIENT POPULATION AND GROWING MIDDLE-CLASS POPULATION TO SUPPORT MARKET GROWTH IN MEXICO
・       TABLE 83..... MEXICO: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 84..... MEXICO: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.5.3              REST OF LATIN AMERICA
・       TABLE 85................ REST OF LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 86................ REST OF LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
9.6             MIDDLE EAST & AFRICA
9.6.1              LACK OF AWARENESS REGARDING CRRT TO RESTRAIN THE MARKET GROWTH IN THE REGION
・       TABLE 87......... MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
・       TABLE 88......... MEA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 89......... MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION)
・       TABLE 90......... MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION)

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          KEY PLAYER STRATEGIES
10.3          REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
・       FIGURE 29.. REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE CRRT MARKET
10.4          GLOBAL MARKET SHARE ANALYSIS (2020)
・       TABLE 91.... CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: DEGREE OF COMPETITION
10.5          COMPETITIVE LEADERSHIP MAPPING
10.5.1            STARS
10.5.2            EMERGING LEADERS
10.5.3            PERVASIVE PLAYERS
10.5.4            PARTICIPANTS
・       FIGURE 30.. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.6          COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
10.6.1            PROGRESSIVE COMPANIES
10.6.2            STARTING BLOCKS
10.6.3            RESPONSIVE COMPANIES
10.6.4            DYNAMIC COMPANIES
・       FIGURE 31.. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020.. 131
10.7          FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
10.7.1            PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
・       TABLE 92........................... INDUSTRY FOOTPRINT OF COMPANIES
・       TABLE 93.......................... REGIONAL FOOTPRINT OF COMPANIES
10.7.1.1          CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: PRODUCT LAUNCHES AND REGULATORY APPROVALS (JANUARY 2018 TO MAY 2021)
・       TABLE 94.. KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
10.7.1.2          CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: DEALS
(JANUARY 2018 TO MAY 2021)
・       TABLE 95.............................................................. KEY DEALS
10.7.1.3          CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO MAY 2021)
・       TABLE 96........................................ KEY OTHER DEVELOPMENTS

11.. COMPANY PROFILES

11.1          MAJOR PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
11.1.1            BAXTER INTERNATIONAL INC.
・       TABLE 97......... BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
・       FIGURE 32....... COMPANY SNAPSHOT: BAXTER INTERNATIONAL INC.
・       TABLE 98........ BAXTER INTERNATIONAL INC.: PRODUCT OFFERINGS
11.1.2            FRESENIUS MEDICAL CARE AG & CO. KGAA
・       TABLE 99..... FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
・       FIGURE 33.. COMPANY SNAPSHOT: FRESENIUS MEDICAL CARE AG & CO. KGAA
・       TABLE 100.... FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS
11.1.3            NIKKISO CO., LTD. 145
・       TABLE 101..................... NIKKISO CO., LTD.: BUSINESS OVERVIEW
・       FIGURE 34..................... COMPANY SNAPSHOT: NIKKISO CO., LTD.
・       TABLE 102..................... NIKKISO CO., LTD.: PRODUCT OFFERINGS
11.1.4            B. BRAUN MELSUNGEN AG
・       TABLE 103.......... B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
・       FIGURE 35.......... COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG
・       TABLE 104......... B. BRAUN MELSUNGEN AG: PRODUCT OFFERINGS
11.1.5            MEDTRONIC PLC
・       TABLE 105....................... MEDTRONIC PLC: BUSINESS OVERVIEW
・       FIGURE 36...................... COMPANY SNAPSHOT: MEDTRONIC PLC
・       TABLE 106...................... MEDTRONIC PLC: PRODUCT OFFERINGS
11.1.6            ASAHI KASEI CORPORATION
・       TABLE 107........ ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
・       FIGURE 37........ COMPANY SNAPSHOT: ASAHI KASEI CORPORATION
・       TABLE 108........ ASAHI KASEI CORPORATION: PRODUCT OFFERINGS
11.1.7            TORAY MEDICAL CO., LTD.
・       TABLE 109........... TORAY MEDICAL CO., LTD.: BUSINESS OVERVIEW
・       FIGURE 38........... COMPANY SNAPSHOT: TORAY MEDICAL CO., LTD.
・       TABLE 110........... TORAY MEDICAL CO., LTD.: PRODUCT OFFERINGS
11.1.8            NIPRO CORPORATION.. 158
・       TABLE 111................ NIPRO CORPORATION: BUSINESS OVERVIEW
・       FIGURE 39................ COMPANY SNAPSHOT: NIPRO CORPORATION
・       TABLE 112................ NIPRO CORPORATION: PRODUCT OFFERINGS
11.1.9            INFOMED SA
・       TABLE 113............................ INFOMED SA: BUSINESS OVERVIEW
・       TABLE 114........................... INFOMED SA: PRODUCT OFFERINGS
11.1.10         MEDICA SPA
・       TABLE 115............................ MEDICA SPA: BUSINESS OVERVIEW
11.1.10.2        Products offered
・       TABLE 116............................ MEDICA SPA: PRODUCT OFFERINGS
11.1.11         MEDITES PHARMA SPOL. S.R.O.. 164
・       TABLE 117..... MEDITES PHARMA SPOL. S.R.O: BUSINESS OVERVIEW
・       TABLE 118.... MEDITES PHARMA SPOL. S.R.O: PRODUCT OFFERINGS
11.1.12         MEDICAL COMPONENTS, INC.
・       TABLE 119...... MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW
・       TABLE 120...... MEDICAL COMPONENTS, INC.: PRODUCT OFFERINGS
11.1.13         SWS HEMODIALYSIS CARE CO. LTD.
・       TABLE 121 SWS HEMODIALYSIS CARE CO. LTD.: BUSINESS OVERVIEW
・       TABLE 122.............. SWS HEMODIALYSIS CARE CO. LTD.: PRODUCT OFFERINGS
11.1.14         NINGBO TIANYI MEDICAL DEVICES CO., LTD.
・       TABLE 123... NINGBO TIANYI MEDICAL DEVICES CO., LTD.: BUSINESS OVERVIEW
・       TABLE 124... NINGBO TIANYI MEDICAL DEVICES CO., LTD.: PRODUCT OFFERINGS
11.1.15         ANJUE MEDICAL EQUIPMENT CO., LTD.
・       TABLE 125.......... ANJUE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW
・       TABLE 126.......... ANJUE MEDICAL EQUIPMENT CO., LTD.: PRODUCT OFFERINGS
11.2.................................................... EMERGING PLAYERS
11.2.1            KIMAL
11.2.2            JIANGXI SANXIN MEDTEC CO., LTD.
11.2.3            ALLMED MEDICAL PRODUCTS CO., LTD.
11.2.4            DIALCO MEDICAL INC.
11.2.5            BROWNDOVE HEALTHCARE PVT. LTD.
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.. APPENDIX

当レポートのプレスリリースは発行されておりません。